Showing results (1401-1410 of 1,456) with videos related to

Sort By:
Pageof 146
Materials (Basel, Switzerland)|April 23, 2022
The Improvement of Durability of Reinforced Concretes for Sustainable Structures: A Review on Different ApproachesLuigi Coppola, Silvia Beretta, Maria Chiara Bignozzi, et al.
Journal of the Neurological Sciences|April 26, 2023
Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability studyA A Tamborska, G K Wood, E Westenberg, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|April 1, 2020
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergencyAlberto Zangrillo, Luigi Beretta, Paolo Silvani, et al.
Journal for Immunotherapy of Cancer|February 1, 2023
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817Neal E Ready, Clarisse Audigier-Valette, Jonathan W Goldman, et al.
Neuroepidemiology|January 25, 2024
Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-AnalysisGiorgia Giussani, Erica Westenberg, David Garcia-Azorin, et al.
Environmental Research|August 18, 2020
Determinants of the current and future distribution of the West Nile virus mosquito vector Culex pipiens in SpainL Gangoso, D Aragonés, J Martínez-de la Puente, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2021
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung CancerHossein Borghaei, Scott Gettinger, Everett E Vokes, et al.
Preventive Medicine|January 14, 2014
Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: the FRESCO StudyJaume Marrugat, Isaac Subirana, Rafel Ramos, et al.
Journal for Immunotherapy of Cancer|July 15, 2020
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trialRobert J Motzer, Bernard Escudier, David F McDermott, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 17, 2020
Factors associated with therapeutic anticoagulation status in patients with ischemic stroke and atrial fibrillationShadi Yaghi, Ava L Liberman, Nils Henninger, et al.
Pageof 146